Cargando…

Inverse Agonistic Action of 3-Iodothyronamine at the Human Trace Amine-Associated Receptor 5

Objective Application of 3-iodothyronamine (3-T(1)AM) results in decreased body temperature and body weight in rodents. The trace amine-associated receptor (TAAR) 1, a family A G protein-coupled receptor, is a target of 3-T(1)AM. However, 3-T(1)AM effects still persist in mTaar1 knockout mice, which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dinter, Juliane, Mühlhaus, Jessica, Wienchol, Carolin Leonie, Yi, Chun-Xia, Nürnberg, Daniela, Morin, Silke, Grüters, Annette, Köhrle, Josef, Schöneberg, Torsten, Tschöp, Matthias, Krude, Heiko, Kleinau, Gunnar, Biebermann, Heike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382497/ https://www.ncbi.nlm.nih.gov/pubmed/25706283 http://dx.doi.org/10.1371/journal.pone.0117774

Ejemplares similares

Differential Modulation of Beta-Adrenergic Receptor Signaling by Trace Amine-Associated Receptor 1 Agonists
por: Kleinau, Gunnar, et al.
Publicado: (2011)

The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor
por: Bräunig, Julia, et al.
Publicado: (2018)

Analysis of Human TAAR8 and Murine Taar8b Mediated Signaling Pathways and Expression Profile
por: Mühlhaus, Jessica, et al.
Publicado: (2014)

Insights into molecular properties of the human monocarboxylate transporter 8 by combining functional with structural information
por: Kleinau, Gunnar, et al.
Publicado: (2011)

G-Protein Coupled Receptor 83 (GPR83) Signaling Determined by Constitutive and Zinc(II)-Induced Activity
por: Müller, Anne, et al.
Publicado: (2013)

Investigation of Naturally Occurring Single-Nucleotide Variants in Human TAAR1
por: Mühlhaus, Jessica, et al.
Publicado: (2017)

Molecular description of non-autoimmune hyperthyroidism at a neonate caused by a new thyrotropin receptor germline mutation
por: Biebermann, Heike, et al.
Publicado: (2011)

The extracellular N-terminal domain of G-protein coupled receptor 83 regulates signaling properties and is an intramolecular inverse agonist
por: Müller, Anne, et al.
Publicado: (2014)

Ring Finger Protein 11 Inhibits Melanocortin 3 and 4 Receptor Signaling
por: Müller, Anne, et al.
Publicado: (2016)

3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?
por: Khajavi, Noushafarin, et al.
Publicado: (2017)

A New Mechanism in THRA Resistance: The First Disease-Associated Variant Leading to an Increased Inhibitory Function of THRA2
por: Paisdzior, Sarah, et al.
Publicado: (2021)

3-Iodothyronamine Activates a Set of Membrane Proteins in Murine Hypothalamic Cell Lines
por: Bräunig, Julia, et al.
Publicado: (2018)

The Pathogenic TSH β-Subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR
por: Kalveram, Laura, et al.
Publicado: (2019)

Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective
por: Heyder, Nicolas, et al.
Publicado: (2019)

Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83
por: Müller, Anne, et al.
Publicado: (2016)

Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
por: Rutigliano, Grazia, et al.
Publicado: (2019)

Modulation of cardiac ionic homeostasis by 3-iodothyronamine
por: Ghelardoni, Sandra, et al.
Publicado: (2009)

TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells
por: Walcher, Lia, et al.
Publicado: (2018)

Update on 3-iodothyronamine and its neurological and metabolic actions
por: Zucchi, Riccardo, et al.
Publicado: (2014)

Structural–Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work
por: Kleinau, Gunnar, et al.
Publicado: (2017)

3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes
por: Gencarelli, Manuela, et al.
Publicado: (2020)

3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern
por: Mariotti, Veronica, et al.
Publicado: (2014)

Uptake of 3‐iodothyronamine hormone analogs inhibits the growth and viability of cancer cells
por: Rogowski, Michael, et al.
Publicado: (2017)

Differential Signaling Profiles of MC4R Mutations with Three Different Ligands
por: Paisdzior, Sarah, et al.
Publicado: (2020)

Vascular Endothelial Growth Factor (VEGF) Induced Downstream Responses to Transient Receptor Potential Vanilloid 1 (TRPV1) and 3-Iodothyronamine (3-T(1)AM) in Human Corneal Keratocytes
por: Türker, Ersal, et al.
Publicado: (2018)

Commentary: 3-Iodothyronamine Reduces Insulin Secretion In Vitro via a Mitochondrial Mechanism
por: Laurino, Annunziatina, et al.
Publicado: (2018)

Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases
por: Laurino, Annunziatina, et al.
Publicado: (2018)

Behavioral hypothermia of a domesticated lizard under treatment of the hypometabolic agent 3-iodothyronamine
por: Ha, Kyoungbong, et al.
Publicado: (2016)

Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1)
por: Gencarelli, Manuela, et al.
Publicado: (2022)

Testosterone production during puberty in two 46,XY patients with disorders of sex development and novel NR5A1 (SF-1) mutations
por: Tantawy, Sally, et al.
Publicado: (2012)

Detection of Novel Gene Variants Associated with Congenital Hypothyroidism in a Finnish Patient Cohort
por: Löf, Christoffer, et al.
Publicado: (2016)

Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine
por: Zhang, Xiaoqun, et al.
Publicado: (2018)

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine
por: Selen Alpergin, Ebru S., et al.
Publicado: (2017)

Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2023)

The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms
por: Müller, Timo D., et al.
Publicado: (2013)

What is hot in experimental thyroidology?
por: Biebermann, Heike
Publicado: (2011)

The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency
por: Köhler, Birgit, et al.
Publicado: (2009)

3-iodothyronamine inhibits apoptosis induced by myocardial ischemia reperfusion via the Akt/FoxO1 signaling pathway
por: Zhou, Haiyan, et al.
Publicado: (2022)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
por: Bellusci, Lorenza, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fn3vij19h0s5bq03gfhsag48ai